- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03765099
Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents
Effects of Animal-Assisted Interactions (AAI) on Quality of Life in Children With Life-Threatening Conditions and Their Parents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives:
Examine the feasibility of animal-assisted interactions sessions for children with a life-threatening condition and primary caregiver to:
- Identify and document modifications for a safe and feasible intervention,
- Obtain recruitment estimates and determine potential recruitment barriers
- Evaluate elements of implementation fidelity (design, training, delivery/receipt of Treatment, enactment)
- Verify safety.
H1-1: Children and parents (>60%) will complete the interventions and provide positive acceptability data. H1-2: Implementation fidelity can be achieved with the proposed methodology
Determine the preliminary efficacy of animal-assisted interactions sessions for:
- Children with a life-threatening condition (LTC) for the outcome of health-related quality of life
- Children with a LTC and their primary caregivers for the outcomes of stress and anxiety
H2-1 Children with a life-threatening condition who receive animal-assisted interactions will experience improved health-related quality of life (HRQOL) more than patients who do not receive animal-assisted interactions.
H2-2a Children with life-threatening condition who receive animal-assisted interactions will experience decreased stress and anxiety more than parents of children who do not receive animal-assisted interactions.
H2-2b Primary caregivers of children with a life-threatening condition who receive animal-assisted interactions will experience decreased stress and anxiety more than parents of children who do not receive animal-assisted interactions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Monroe Carell Jr Children's Hospital at Vanderbilt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children 3-17 years old
- Confirmed diagnosis of relapsed or refractory cancer
Exclusion Criteria:
- Reported fear or anxiety of dogs (child or parent)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Animal-Assisted Interactions
Children and their caregivers randomly assigned to the intervention group will spend approximately 15 min with a registered canine and its owner during potentially anxiety-producing visits to the hospital.
|
Child and caregivers randomly assigned to the intervention group will spend approximately 15 min with a registered canine and its owner during potentially anxiety-producing visits to the hospital.
Other Names:
|
|
Active Comparator: Usual Care
Children and their caregivers randomly assigned to the usual care group will receive usual care which may include play therapy, music therapy or visits with a social worker during their visits to the hospital.
|
Child and caregivers randomly assigned to the intervention group will spend approximately 15 min with a registered canine and its owner during potentially anxiety-producing visits to the hospital.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pediatric Quality of Life
Time Frame: up to 3 months
|
The Peds Quality of Life measure will be administered to children and their parents (proxy) once a month
|
up to 3 months
|
|
Anxiety
Time Frame: up to 3 months
|
The state-trait anxiety inventory will be administered to children and their parents after each intervention or usual care visit
|
up to 3 months
|
|
Stress
Time Frame: up to 3 months
|
Saliva samples to measure cortisol levels will be administered to children after animal-assisted interventions or after completion of measures in usual care group
|
up to 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Maryjo Gilmer, PhD, Vanderbilt Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- VICC PED 18166
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Cancer
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
-
Icahn School of Medicine at Mount SinaiNational Institute of Nursing Research (NINR)Not yet recruitingAdvanced Heart Failure | Advanced Lung Cancer | Advanced Triple Negative Breast Cancer | Advanced Non-Colorectal Gastrointestinal CancerUnited States
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
STORM Therapeutics LTDCompletedCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
PfizerRecruitingAdvanced Cancer | Advanced MalignanciesUnited States
-
Shanghai Allink Biotherapeutics Co., Ltd.RecruitingAdvanced Solid Tumor | Advanced CancerAustralia, United States
-
Chinese PLA General HospitalNot yet recruitingTreatment for Advanced Colorectal Cancer | Treatment for Advanced Pancreatic Cancer
Clinical Trials on Animal-Assisted Interactions
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Vanderbilt UniversityCompletedChild Development | Learning Problem | Animal-Human BondingUnited States
-
Atlas UniversityNot yet recruitingDepression | Loneliness | Old Age; Debility | Nursing Home | Loss of Interest in Activities
-
Norwegian University of Life SciencesCompleted
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoPurina España (Reg. Trademark of Nestle S.A.)Enrolling by invitationEating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/BulimiaSpain
-
Daniel Collado-MateoAsociación de Padres de Personas Con Autismo (APNA); Asociación Nuevo Horizonte and other collaboratorsEnrolling by invitationAutism Spectrum Disorder | AutismSpain
-
Washington State UniversityCompletedStress, Psychological | Stress, Physiological
-
Uskudar UniversityNot yet recruiting
-
Chang Gung Memorial HospitalUnknownSchizophrenia | Animal-assisted TherapyTaiwan